Brenda Grossman

Medicine & Life Sciences

1. Photopheresis 100%
2. Tissue Donors 80%
3. Blood Donors 67%
4. Coronavirus 61%
5. Erythrocyte Transfusion 53%
6. Practice Guidelines 49%
7. Thrombotic Thrombocytopenic Purpura 47%
8. Platelet Transfusion 44%
9. Antibodies 44%
10. Graft vs Host Disease 40%
11. Blood Banks 37%
12. Transfusion-Related Acute Lung Injury 36%
13. Hematopoietic Stem Cells 35%
14. Systematic Reviews 34%
15. Viral Antibodies 34%
16. Hematopoietic Stem Cell Mobilization 33%
17. Plasma Exchange 32%
18. plerixafor octahydrochloride 32%
19. Erythrocytes 31%
20. Transfusion Reaction 31%
21. SARS Virus 27%
22. Randomized Controlled Trials 27%
23. Transplants 27%
24. Cytomegalovirus Infections 26%
25. Allogeneic Cells 25%
26. Blood Platelets 25%
27. Blood Component Removal 24%
28. Safety 24%
29. Vaccination 23%
30. Transfusion Medicine 22%
31. Liver Transplantation 21%
32. Blood Buffy Coat 21%
33. Hemoglobins 20%
34. Therapeutics 20%
35. Allografts 20%
36. Meta-Analysis 20%
37. Influenza Vaccines 20%
38. Hepatitis B Core Antigens 19%
39. Healthcare Failure Mode and Effect Analysis 19%
40. Hemoglobin C 19%
41. Haploidentical Transplantation 19%
42. Mortality 19%
43. Observational Studies 18%
44. cold agglutinins 18%
45. Peripheral Blood Stem Cells 18%
46. Bronchiolitis Obliterans 18%
47. Hemorrhage 18%
48. Cytomegalovirus 17%
49. Odds Ratio 17%
50. Confidence Intervals 17%